期刊
CURRENT ONCOLOGY REPORTS
卷 11, 期 3, 页码 193-199出版社
SPRINGER
DOI: 10.1007/s11912-009-0028-0
关键词
-
类别
资金
- National Cancer Institute [P50 CA127003]
- Caring for Carcinoid Foundation
- Stephen and Caroline Kaufer fund for neuroendocrine tumor research
Traditional treatments for patients with advanced neuroendocrine tumors include surgical debulking, hepatic embolization, somatostatin analogues, and interferon-alpha. Patients with pancreatic neuroendocrine tumors also may benefit from treatment with the alkylating agents streptozocin or temozolomide. In recent years, several promising new approaches have been investigated in patients with advanced neuroendocrine tumors. One such approach has been the use of radiopeptide therapy targeting somatostatin receptors. Additionally, agents targeting the vascular endothelial growth factor pathway and mammalian target of rapamycin have shown preliminary evidence of activity and are currently being evaluated in large randomized studies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据